ResearcherTUM KlinikumActive in the last 2 years
Rüdiger Göß
Matched on ORCID iD 0000-0002-0407-0394; OpenAlex author ID A5109095251. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 37
2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 3 papers · 2025: 2 papers
Papers 9
- Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. First author DOI 10.1016/j.canlet.2025.217894↗
- Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdifferentiation. Co-author DOI 10.1016/j.neo.2025.101126↗
- A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patients. Co-author DOI 10.1007/s00423-024-03570-y↗
- Correlation of intratumoral mast cell quantity with psychosocial distress in patients with pancreatic cancer: the PancStress study. First author DOI 10.1038/s41598-024-77010-8↗
- Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. Co-author DOI 10.1093/bjsopen/zrad125↗
- Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. Co-author DOI 10.1097/as9.0000000000000302↗
- Patterns and Relevance of Langerhans Islet Invasion in Pancreatic Cancer. Co-author DOI 10.3390/cancers13020249↗
- A look at the progress of treating pancreatic cancer over the past 20 years. Co-author DOI 10.1080/14737140.2018.1428093↗
- The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis. Co-author DOI 10.1016/j.suronc.2017.01.007↗
Closest collaborators
The 25 strongest of 37 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- İhsan Ekin Demir · 8 shared papers, 2017–2025 · strength 1.29
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdiffer… DOI 10.1016/j.neo.2025.101126↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Guralp Onur Ceyhan · 8 shared papers, 2017–2025 · strength 1.29
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdiffer… DOI 10.1016/j.neo.2025.101126↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Helmut Friess · 7 shared papers, 2017–2025 · strength 1.17
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdiffer… DOI 10.1016/j.neo.2025.101126↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Okan Safak · 6 shared papers, 2021–2025 · strength 0.99
- Paper Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdiffer… DOI 10.1016/j.neo.2025.101126↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Ilaria Pergolini · 5 shared papers, 2023–2025 · strength 0.89
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Carmen Mota Reyes · 5 shared papers, 2017–2025 · strength 0.82
- Paper Pancreatic cancer cells survive in the neural niche during neoadjuvant therapy. DOI 10.1016/j.canlet.2025.217894↗
- Paper Pancreatic cancer cells infiltrate nerves through TGFbeta1-driven perineural epithelial-to-mesenchymal-like transdiffer… DOI 10.1016/j.neo.2025.101126↗
- Paper Correlation of intratumoral mast cell quantity with psychosocial distress in patients with pancreatic cancer: the PancS… DOI 10.1038/s41598-024-77010-8↗
- Stephan Schorn · 4 shared papers, 2017–2024 · strength 0.56
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Paper A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patien… DOI 10.1007/s00423-024-03570-y↗
- Alexander Novotny · 3 shared papers, 2023–2024 · strength 0.49
- Paper Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study. DOI 10.1093/bjsopen/zrad125↗
- Paper Arterial Resection for Pancreatic Cancer: Feasibility and Current Standing in a High-Volume Center. DOI 10.1097/as9.0000000000000302↗
- Paper A retrospective, multicentric, nationwide analysis of the impact of splenectomy on survival of pancreatic cancer patien… DOI 10.1007/s00423-024-03570-y↗
- Alexander Muckenhuber · 2 shared papers, 2024–2025 · strength 0.42
- Marc Eric Martignoni · 2 shared papers, 2023–2024 · strength 0.30
- Maximilian Kießler · 2 shared papers, 2023–2024 · strength 0.30
- Helmut Frieß · 2 shared papers, 2018–2021 · strength 0.29
- Lei Ren · 2 shared papers, 2021–2023 · strength 0.29
- Florian Scheufele · 2 shared papers, 2017–2024 · strength 0.25
- Kaan Çifcibaşı · 1 shared paper, 2025 · strength 0.24
- Theresa Krauss · 1 shared paper, 2025 · strength 0.22
- Dieter Saur · 1 shared paper, 2025 · strength 0.22
- Mustapha Adham · 1 shared paper, 2024 · strength 0.18
- Julie Périnel · 1 shared paper, 2024 · strength 0.18
- Alicia Sitte · 1 shared paper, 2024 · strength 0.16
- Paulo Leonardo Pfitzinger · 1 shared paper, 2024 · strength 0.16
- Mert Erkan · 1 shared paper, 2024 · strength 0.16
- Werner Hartwig · 1 shared paper, 2024 · strength 0.14
- Tim R. Glowka · 1 shared paper, 2024 · strength 0.14
- Tobias Keck · 1 shared paper, 2024 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.